What is Elixir Medical's business focus and history?

Elixir Medical Corporation is a privately held company based in Milpitas, California, founded in 2005 by Motasim Sirhan. It specializes in developing innovative medical devices combined with advanced pharmaceuticals to provide treatment solutions for cardiovascular patients. The company has received Series A funding from Invus. Elixir Medical's key products include the DynamX Coronary Bioadaptor, LithiX Hertz Contact Lithotripsy Catheter, and DESyne X2 Novolimus Eluting Coronary Stent System.

Elixir Medical Corporate Details & Core Services

Elixir Medical Corporation is a privately held company specializing in developing innovative medical devices combined with advanced pharmaceuticals to provide treatment solutions for cardiovascular patients.

Elixir Medical Contact Information & Official Links

Website https://elixirmedical.com
Social
Email id info@elixirmedical.com
Phone number +1.408.636.2000
Head office address Milpitas, California, United States
Tags Medical Devices Pharmaceuticals Cardiovascular Treatment

What are Elixir Medical's Key Business Metrics & Stats?

No of employees
Founded year 2005
Type private
Industry Medical Devices
Location Milpitas, California, United States
Elixir Medical Firmographic Snapshot 2026 2005 Founded Year Global Employees United States Headquarters MedicalDevices Industry Private Type Verified by DexterAgent.ai

How much funding has Elixir Medical raised to date?

Name Description
Stage Series A
Latest Valuation (USD)
Lead Investor Invus
Investors Invus

What are Elixir Medical's Core Products?

Name Description
DynamX Coronary Bioadaptor A coronary implant designed to restore blood flow and allow the artery to return to its natural physiology, motion, and function.
LithiX Hertz Contact Lithotripsy Catheter A catheter designed to use Hertz contact stress to fracture calcium, enhancing deliverability, safety, and simplicity of use.
DESyne X2 Novolimus Eluting Coronary Stent System A drug-eluting stent system designed to optimize localized drug delivery for cardiovascular patients.

What are the latest developments at Elixir Medical?

Date Type Description
October, 2008 Clinical Trial Results Elixir Medical announced positive first-in-man results from three drug-eluting coronary stent systems.
Name Description
Legal Name Elixir Medical Corporation
Cin number
GST number
Registration number

Who is in Elixir Medical's executive leadership team?

Name Designation
CEO Motasim Sirhan
President & Chief Operating Officer Vinayak Bhat PhD
Chief Technology Officer John Yan
Executive Vice President, Clinical Research Candace Elek
Executive Vice President, Research & Development Howard Huang
Executive Vice President, Operations Andrew Kramer
Executive Vice President, Global Marketing Alex Nepogodiev

Where are Elixir Medical's primary office locations?

City Country
Milpitas United States

What are the current business signals and market intelligence for Elixir Medical?

Pain points Cardiovascular Disease Treatment, Coronary Artery Disease, Peripheral Artery Disease
Sales motion Direct Sales, Partnerships with Healthcare Institutions
Buyer Persona Cardiologists, Hospital Procurement Managers, Healthcare Administrators
Type of customer Healthcare Providers, Hospitals, Cardiologists
Key customer domain

What are Elixir Medical's risk management and compliance ratings?

GDPR RIsk No
Privacy Risk No
Company Ratings
Glassdoor Rating

What are Elixir Medical's business model and service classifications?

Saas No
Offline Stores No
Service Yes
Ecommerce No
Exporter Yes
Mobile App No
Retail No
B2B Yes
B2C No
Manufacturing Yes
Wholesale No
Importer No
Get Company Intelligence in API
(Price is 0.1 USD/Record - pay as you go)

 

Get Company Intelligence in API
(Price is 0.1 USD/Record - pay as you go)